Skip to main content
Top
Published in: Rheumatology International 7/2009

01-05-2009 | Case Report

Antiphospholipid syndrome presenting as unilateral renal artery occlusion: case report and literature review

Authors: Doron Boltin, Victoria Boguslavski, Lior Sagi, Yoav Goor, Ori Elkayam

Published in: Rheumatology International | Issue 7/2009

Login to get access

Abstract

The objective of this study is to report a case of primary antiphospholipid syndrome (APS) presenting as complete renal artery occlusion, and to review the literature on the subject. We describe the clinical presentation, course and outcome of one patient who presented with resistant hypertension later found to be due to thrombosis and complete occlusion of the left renal artery. We review the medical literature registered in the Medline PubMed database from 1966 to 2004 using keywords: antiphospholipid, Hughes syndrome, kidney, renal, renal artery thrombosis. We describe one patient and analyzed ten well-documented cases of renal artery thrombosis due to APS. Most of the patients were women, at a mean age of 32 years. All but one case had primary APS. The presenting symptom was hypertension in ten cases. Most patients had both lupus anticoagulant and anticardiolipin antibodies. Arterial occlusion was left sided in 55%, right sided in 27% and bilateral in 18%. Renal artery thrombosis is an uncommon presentation of APS. This entity should be considered in the differential diagnosis of severe hypertension.
Literature
1.
2.
go back to reference Asherson RA, Noble GE, Hughes GRV (1991) Hypertension, renal artery stenosis and the “primary” antiphospholipid syndrome. J Rheumatol 18(9):1413–1415PubMed Asherson RA, Noble GE, Hughes GRV (1991) Hypertension, renal artery stenosis and the “primary” antiphospholipid syndrome. J Rheumatol 18(9):1413–1415PubMed
3.
go back to reference Ames PRJ, Cianciaruso B, Bellizzi V et al (1992) Bilateral renal artery occlusion in a patient with primary antiphospholipid antibody syndrome: thrombosis, vasculitis or both? J Rheumatol 19(11):1802–1806PubMed Ames PRJ, Cianciaruso B, Bellizzi V et al (1992) Bilateral renal artery occlusion in a patient with primary antiphospholipid antibody syndrome: thrombosis, vasculitis or both? J Rheumatol 19(11):1802–1806PubMed
4.
go back to reference Mandreoli M, Zuccala A, Zucchelli P (1992) Fibromuscular dysplasia of the renal arteries associated with antiphospholipid autoantibodies: two case reports. Am J Kidney Dis 20(5):500–503PubMed Mandreoli M, Zuccala A, Zucchelli P (1992) Fibromuscular dysplasia of the renal arteries associated with antiphospholipid autoantibodies: two case reports. Am J Kidney Dis 20(5):500–503PubMed
5.
go back to reference Sonpal GM, Sharma A, Miller A (1993) Primary antiphospholipid antibody syndrome, renal infarction and hypertension. J Rheumatol 20(7):1221–1223PubMed Sonpal GM, Sharma A, Miller A (1993) Primary antiphospholipid antibody syndrome, renal infarction and hypertension. J Rheumatol 20(7):1221–1223PubMed
6.
go back to reference Domrongkitchaiporn S, Cameron EC, Jetha N, Kassen BO, Sutton RA (1994) Renal microangiopathy in the primary antiphospholipid syndrome: a case report with literature review. Nephron 68(1):128–132PubMedCrossRef Domrongkitchaiporn S, Cameron EC, Jetha N, Kassen BO, Sutton RA (1994) Renal microangiopathy in the primary antiphospholipid syndrome: a case report with literature review. Nephron 68(1):128–132PubMedCrossRef
8.
10.
go back to reference Krishnan P, Anandh U, Fernandes DK, Somiah S, Vincent L (2002) Renal failure in a patient with primary antiphospholipid syndrome. J Assoc Physicians India 50:964–966PubMed Krishnan P, Anandh U, Fernandes DK, Somiah S, Vincent L (2002) Renal failure in a patient with primary antiphospholipid syndrome. J Assoc Physicians India 50:964–966PubMed
11.
go back to reference Poux JM, Boudet R, Lacroix P et al (1996) Renal infarction and thrombosis of the infrarenal aorta in a 35-year-old with primary antiphospholipid syndrome. Am J Kid Dis 27(5):721–725PubMedCrossRef Poux JM, Boudet R, Lacroix P et al (1996) Renal infarction and thrombosis of the infrarenal aorta in a 35-year-old with primary antiphospholipid syndrome. Am J Kid Dis 27(5):721–725PubMedCrossRef
13.
go back to reference Lockshin MD (2006) Update on antiphospholipid syndrome. Bull NYU Hosp Jt Dis 64(1–2):57–59PubMed Lockshin MD (2006) Update on antiphospholipid syndrome. Bull NYU Hosp Jt Dis 64(1–2):57–59PubMed
14.
go back to reference Cervera R, Piette JC, Fornt J (2002) Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1, 000 patients. Arthritis Rheum 46(4):1019–1027. doi:10.1002/art.10187 PubMedCrossRef Cervera R, Piette JC, Fornt J (2002) Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1, 000 patients. Arthritis Rheum 46(4):1019–1027. doi:10.​1002/​art.​10187 PubMedCrossRef
15.
go back to reference Moss KE, Isenberg DA (2001) Comparison of renal disease severity and outcome in patients with primary antiphospholipid syndrome, antiphospholipid syndrome secondary to systemic lupus erythematosus (SLE) and SLE alone. Rheumatology (Oxford) 40(8):863–867. doi:10.1093/rheumatology/40.8.863 CrossRef Moss KE, Isenberg DA (2001) Comparison of renal disease severity and outcome in patients with primary antiphospholipid syndrome, antiphospholipid syndrome secondary to systemic lupus erythematosus (SLE) and SLE alone. Rheumatology (Oxford) 40(8):863–867. doi:10.​1093/​rheumatology/​40.​8.​863 CrossRef
19.
go back to reference Tektonidou MG, Sotsiou F, Nakopoulou L, Vlachoyiannopoulos PG, Moutsooulos HM (2004) Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome. Arthritis Rheum 50(8):2569–2574. doi:10.1002/art.20433 PubMedCrossRef Tektonidou MG, Sotsiou F, Nakopoulou L, Vlachoyiannopoulos PG, Moutsooulos HM (2004) Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome. Arthritis Rheum 50(8):2569–2574. doi:10.​1002/​art.​20433 PubMedCrossRef
20.
go back to reference Fastenau Wagenknecht DR, DR Torry RJ et al (2000) Risk of early renal allograft failure is increased for patients with antiphospholipid antibodies. Transpl Int 13(Suppl 1):S78–S81. doi:10.1007/s001470050280 PubMed Fastenau Wagenknecht DR, DR Torry RJ et al (2000) Risk of early renal allograft failure is increased for patients with antiphospholipid antibodies. Transpl Int 13(Suppl 1):S78–S81. doi:10.​1007/​s001470050280 PubMed
21.
go back to reference Perez RE, McClendon JR, Lie JT (1992) Primary antiphospholipid antibody syndrome with multiorgan arterial and venous thrombosis. J Rheumatol 19(8):1289–1292PubMed Perez RE, McClendon JR, Lie JT (1992) Primary antiphospholipid antibody syndrome with multiorgan arterial and venous thrombosis. J Rheumatol 19(8):1289–1292PubMed
22.
go back to reference Mintz G, Acevedo-Vazquez E, Gutierrez-Espinosa GF, Avelar-Garnica F (1984) Renal vein thrombosis and inferior vena cava thrombosis in systemic lupus erythematosus. Frequency and risk factors. Arthritis Rheum 27(5):539–544. doi:10.1002/art.1780270509 PubMedCrossRef Mintz G, Acevedo-Vazquez E, Gutierrez-Espinosa GF, Avelar-Garnica F (1984) Renal vein thrombosis and inferior vena cava thrombosis in systemic lupus erythematosus. Frequency and risk factors. Arthritis Rheum 27(5):539–544. doi:10.​1002/​art.​1780270509 PubMedCrossRef
Metadata
Title
Antiphospholipid syndrome presenting as unilateral renal artery occlusion: case report and literature review
Authors
Doron Boltin
Victoria Boguslavski
Lior Sagi
Yoav Goor
Ori Elkayam
Publication date
01-05-2009
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 7/2009
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-008-0779-1

Other articles of this Issue 7/2009

Rheumatology International 7/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.